Cargando…
Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles
Low-molecular-weight heparin/protamine microparticles (LMW-H/P MPs) were produced as a carrier for heparin-binding growth factors (GFs) and for various adhesive cells. A mixture of low-molecular-weight heparin (MW: approximately 5000 Da, 6.4 mg/mL) and protamine (MW: approximately 3000 Da, 10 mg/mL)...
Autores principales: | Kishimoto, Satoko, Ishihara, Masayuki, Takikawa, Megumi, Mori, Yasutaka, Hattori, Hidemi, Fujita, Masanori, Nakamura, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834902/ https://www.ncbi.nlm.nih.gov/pubmed/24300179 http://dx.doi.org/10.3390/pharmaceutics4010042 |
Ejemplares similares
-
Biomedical Application of Low Molecular Weight Heparin/Protamine Nano/Micro Particles as Cell- and Growth Factor-Carriers and Coating Matrix
por: Ishihara, Masayuki, et al.
Publicado: (2015) -
Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier
por: Mori, Yasutaka, et al.
Publicado: (2010) -
Three-Dimensional Expansion Using Plasma-Medium Gel with Fragmin/Protamine Nanoparticles and FGF-2 to Stimulate Adipose-Derived Stromal Cells and Bone Marrow-Derived Mesenchymal Stem Cells
por: Kishimoto, Satoko, et al.
Publicado: (2012) -
Recent Progress on Heparin–Protamine Particles for Biomedical Application
por: Hata, Yuuki, et al.
Publicado: (2022) -
Protective effect of FGF-2 and low-molecular-weight heparin/protamine nanoparticles on radiation-induced healing-impaired wound repair in rats
por: Kinoda, Jun, et al.
Publicado: (2018)